StockClub

SHPMY

SHPMYShanghai Pharmaceuticals Holding Co., Ltd$ --
Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd

SHPMY

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
73,095M CNY
YoY +4.1%
Operating Income
1,463M CNY
YoY -20.4%
Net Income
685M CNY
YoY -38.4%
EPS
0.95CNY
YoY -36.7%

Revenue

CNY214.7B
FY2023 Q4CNY260.1B
CNY260.1B
Q4
FY2024 Q1CNY69.9B
CNY69.9B
Q1
FY2024 Q2CNY139B
CNY139B
Q2
FY2024 Q3CNY209.2B
CNY209.2B
Q3
FY2024 Q4CNY274.9B
CNY274.9B
Q4
FY2025 Q1CNY70.8B
CNY70.8B
Q1
FY2025 Q2CNY141.6B
CNY141.6B
Q2
FY2025 Q3CNY214.7B
CNY214.7B
Q3
Actual
+CNY5.5B (+2.6%)

Net Income

CNY5.1B
FY2023 Q4CNY3.8B
CNY3.8B
Q4
FY2024 Q1CNY1.5B
CNY1.5B
Q1
FY2024 Q2CNY2.9B
CNY2.9B
Q2
FY2024 Q3CNY4.1B
CNY4.1B
Q3
FY2024 Q4CNY4.6B
CNY4.6B
Q4
FY2025 Q1CNY1.3B
CNY1.3B
Q1
FY2025 Q2CNY4.5B
CNY4.5B
Q2
FY2025 Q3CNY5.1B
CNY5.1B
Q3
Actual
+CNY1.1B (+26.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2019
Actual:CNY186.6B
FY2019
CNY186.6B
FY2020
Actual:CNY191.9B
FY2020
CNY191.9B
FY2021
Actual:CNY215.8B
FY2021
CNY215.8B
FY2022
Actual:CNY232B
FY2022
CNY232B
FY2023
Actual:CNY260.3B
FY2023
CNY260.3B
FY2024MISS
Actual:CNY275.3B
Est:CNY281.3B
FY2024MISS
CNY275.3B

Analyst Estimates